DSP 1200Alternative Names: DSP-1200
Latest Information Update: 20 May 2016
At a glance
- Originator Sumitomo Dainippon Pharma
- Class Antidepressants
- Mechanism of Action Alpha 2a adrenergic receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Depressive disorders
Most Recent Events
- 31 Mar 2016 Phase-I clinical trials in Depressive disorders (Treatment-resistant) in USA (PO) before March 2016